IFP Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6K | Buy |
+4,810
| New | +$10.6K | ﹤0.01% | 2880 |
|
|
2023
Q1 | – | Sell |
-16
| Closed | -$2K | – | 4069 |
|
|
2022
Q4 | $2K | Sell |
16
-1
| -6% | -$125 | ﹤0.01% | 4190 |
|
|
2022
Q3 | $3K | Hold |
17
| – | – | ﹤0.01% | 4242 |
|
|
2022
Q2 | $3K | Hold |
17
| – | – | ﹤0.01% | 4006 |
|
|
2022
Q1 | $3K | Buy |
+17
| New | +$3K | ﹤0.01% | 4006 |
|
|
2021
Q4 | – | Sell |
-2
| Closed | -$1K | – | 3395 |
|
|
2021
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 3010 |
|
|
2021
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 2888 |
|
|
2021
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 2816 |
|
|
2020
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 2762 |
|
|
2020
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 2649 |
|
|
2020
Q2 | $1K | Sell |
2
-2
| -50% | -$1K | ﹤0.01% | 2543 |
|
|
2020
Q1 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 2347 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3341 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3437 |
|
|
2019
Q1 | $21K | Sell |
41
-32
| -44% | -$16.4K | ﹤0.01% | 1331 |
|
|
2018
Q4 | $37K | Sell |
73
-112
| -61% | -$56.8K | ﹤0.01% | 1771 |
|
|
2018
Q3 | $169K | Buy |
185
+75
| +68% | +$68.5K | 0.01% | 1166 |
|
|
2018
Q2 | $81K | Sell |
110
-3
| -3% | -$2.21K | ﹤0.01% | 1598 |
|
|
2018
Q1 | $101K | Hold |
113
| – | – | ﹤0.01% | 1383 |
|
|
2017
Q4 | $101K | Buy |
113
+1
| +0.9% | +$894 | ﹤0.01% | 1381 |
|
|
2017
Q3 | $40K | Hold |
112
| – | – | ﹤0.01% | 2119 |
|
|
2017
Q2 | $33K | Sell |
112
-60
| -35% | -$17.7K | ﹤0.01% | 2235 |
|
|
2017
Q1 | $61K | Buy |
172
+61
| +55% | +$21.6K | ﹤0.01% | 1791 |
|
|
2016
Q4 | $20K | Buy |
111
+1
| +0.9% | +$180 | ﹤0.01% | 2447 |
|
|
2016
Q3 | $28K | Buy |
110
+10
| +10% | +$2.55K | ﹤0.01% | 2179 |
|
|
2016
Q2 | $21K | Buy |
100
+59
| +144% | +$12.4K | ﹤0.01% | 2303 |
|
|
2016
Q1 | $21K | Sell |
41
-65
| -61% | -$33.3K | ﹤0.01% | 1331 |
|
|
2015
Q4 | $27K | Buy |
+106
| New | +$27K | ﹤0.01% | 1976 |
|